Integra LifeSciences IART Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's increase (decrease) in other operating assets?
- Integra LifeSciences (IART) reported increase (decrease) in other operating assets of -$1.39M in Q1 2026.
- How has Integra LifeSciences's increase (decrease) in other operating assets changed year-over-year?
- Integra LifeSciences's increase (decrease) in other operating assets increased by 8.3% year-over-year, from -$1.51M to -$1.39M.
- What is the long-term trend for Integra LifeSciences's increase (decrease) in other operating assets?
- Over 3 years (2022 to 2025), Integra LifeSciences's increase (decrease) in other operating assets has grown at a 15.3% compound annual growth rate (CAGR), from $2.18M to -$3.34M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.